Physician

Deborah Michelle Pavey, MD

According to 2025 Medicare claims, Deborah Pavey, MD (NPI: 1417577271) practices family practice in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is BEACON MEDICAL GROUP, INC. (NPI: 1639129117; TIN: 351536132) and primary practice location at 46350-5533. Pavey is affiliated with the CHA ACO, LLC (ACO ID: A2207), participating under the MSSP model.

Pavey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 369 traditional Medicare patients, billed 1,900 HCPCS/CPT codes, and received $93,299 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,564 prescription claims across 630 beneficiaries totaling $326,504 in drug costs, led by Ozempic (Semaglutide). DME data shows 26 claims. Open Payments data shows 38 records totaling $778. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,393 to $326,504. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	131	332	$20,404
2024	369	1,900	$93,299

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	16	54	$6,393
2021	43	375	$38,260
2022	58	976	$128,112
2023	163	1,188	$137,330
2024	630	4,564	$326,504

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	26	$6,752

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	147	147	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	261	416	$81
99497	Advance care planning, first 30 minutes	138	138	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	195	269	$11
36415	Insertion of needle into vein for collection of blood sample	244	371	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	45	1,624	$53,170
Jardiance	Empagliflozin	21	1,410	$27,506
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	47	1,277	$20,201
Eliquis	Apixaban	21	1,030	$19,442
Xarelto	Rivaroxaban	14	710	$13,784

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$6,352
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	11	$400

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$778	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deborah Michelle Pavey, MD?

Tedicare shows public-source Medicare data for Deborah Michelle Pavey, MD (NPI 1417577271), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deborah Michelle Pavey, MD have ACO affiliation data?

Deborah Michelle Pavey, MD is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207).

What billing organization is linked to Deborah Michelle Pavey, MD?

Deborah Michelle Pavey, MD is linked to BEACON MEDICAL GROUP, INC. (billing NPI 1639129117) in the available physician profile data.

Does Deborah Michelle Pavey, MD have Open Payments data?

Deborah Michelle Pavey, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.